Skip to main content
Toxicological Sciences logoLink to Toxicological Sciences
. 2011 Feb 9;121(1):160–167. doi: 10.1093/toxsci/kfr033

Manganese Accumulation in the Olfactory Bulbs and Other Brain Regions of “Asymptomatic” Welders

Suman Sen *,†,§, Michael R Flynn , Guangwei Du §, Alexander I Tröster *, Hongyu An , Xuemei Huang §,1
PMCID: PMC3080190  PMID: 21307282

Abstract

Welding-generated metallic fumes contain a substantial amount of manganese (Mn), making welders susceptible to Mn toxicity. Although overt Mn toxicity manifests as a type of parkinsonism, the consequences of chronic, low-level Mn exposure are unknown. To explore region-specific Mn accumulation and its potential functional consequences at subclinical levels of Mn exposure, we studied seven welders without obvious neurological deficits and seven age- and gender-matched controls. Mn exposure for welders was estimated by an occupational questionnaire. High-resolution brain magnetic resonance imaging (MRI), Grooved Pegboard performance of both hands, Trail making, and olfactory function tests were obtained from all subjects. Compared with controls, the welders had a significantly higher T1 relaxation rate (R1) in the olfactory bulb (OB, p = 0.02), mean T1-weighted intensity at frontal white matter (FWM; p = 0.01), bilateral globus pallidus (GP; p = 0.03), and putamen (p = 0.03). The welders scored worse than the controls on the Grooved Pegboard test for both dominant (p = 0.06) and nondominant hand (p = 0.03). The dominant hand Grooved Pegboard scores correlated best with mean MRI intensity of FWM (R2 = 0.51, p = 0.004), GP (R2 = 0.51, p = 0.004), putamen (R2 = 0.49, p= 0.006), and frontal gray matter (R2 = 0.42, p = 0.01), whereas the nondominant hand scores correlated best with intensity of FWM (R2 = 0.37, p = 0.02) and GP (R2 = 0.28, p = 0.05). No statistical differences were observed in either the Trail-making test or the olfactory test between the two groups. This study suggests that Mn accumulates in OB and multiple other brain regions in “asymptomatic” welders and that MRI abnormalities correlate with fine motor but not cognitive deficits. Further investigations of subclinical Mn exposure are warranted.

Keywords: welding, manganese, MRI, olfactory bulb


Welding fumes generated during the welding process are a well-known source of hazardous toxicants in the form of submicron metal particulates (OSHA, 2009). Constituents of welding fumes vary depending on the type of welding rod being used and the type of metal being welded, with iron (Fe) and manganese (Mn) being the two most common cations that are generated (Jenkins and Eagar, 2005; Sowards et al., 2010). Of these metals, Mn has been well documented as a neurotoxicant for over a 100 years (Couper, 1837) and has been studied extensively in the past (Guilarte, 2010; Meyer-Baron et al., 2009). Mn toxicity is manifested by a neurological syndrome called manganism that initially consists of reduced response speed, irritability, intellectual deficits, mood changes, and compulsive behaviors. This may progress to more prominent, irreversible extrapyramidal dysfunction upon protracted exposure (Huang et al., 1993; Mergler and Baldwin, 1997; Olanow et al., 1996; Pal et al., 1999). Despite similarities between manganism/Mn-induced parkinsonism and Parkinson's disease (PD), recent studies reveal clinically discernible differences (Chu et al., 1995; Guilarte, 2010; Ostiguy et al., 2006). Although any link to sporadic PD remains obscure, the potential neurobehavioral consequences of subclinical Mn exposure are of great public and occupational health importance.

The major health-relevant route of Mn exposure is inhalation (Environmental Protection Agency, 2010). Analyses of welding vapors indicate that Mn is predominantly in the divalent or trivalent states (Jenkins and Eagar, 2005). In gas metal arc welding fumes, Mn is enriched in primary spherical particles of < 0.06μm (Sowards et al., 2010), sizes that can be easily inhaled. Once inhaled, these very small particles will deposit with relatively high efficiencies in the nasopharyngeal and alveolar regions due to diffusion. Welding fumes in the respiratory tract are either cleared by the mucociliary apparatus or absorbed systemically (Lam et al., 1978). Many recent studies using laboratory animals have shown distribution of Mn to the brain after tracheal instillation (Heilig et al., 2006), ip injection (Reaney et al., 2006), or aerosol exposure (Antonini et al., 2009; Dorman et al., 2001, 2006a,b; Elder et al. 2006). An alternate pathway for Mn transport to the brain is via the olfactory route, bypassing the blood-brain barrier (BBB). Rodent and other animal studies (Elder et al., 2006) suggest that metal particles deposited in the nose can be transported along the olfactory nerve directly into the olfactory bulb (OB) and further into the central nervous system, bypassing the protective BBB.

Mn is a paramagnetic metal that reduces the T1 relaxation time of magnetic resonance imaging (MRI), increasing the T1-weighted (T1W) intensity of brain structures (Newland et al., 1989) and the T1 relaxation rate (R1) (Dorman et al., 2006b). MRI has been extensively used to visualize Mn deposition in rodents (Fitsanakis et al., 2008; Silva and Bock, 2008), nonhuman primates (Bock et al., 2008; Dorman et al., 2006b; Newland et al., 1989), and in humans with manganism (Quaghebeur et al., 1996; Selikhova et al., 2008; Stepens et al., 2008). MRI has also been used previously to demonstrate Mn deposition in welders (Bowler et al., 2006b; Chang et al., 2009, 2010; Choi et al., 2007; da Silva et al., 2008). Nearly all MRI studies in humans, however, have focused on the pallidus with little attention to other regions. To our knowledge, there is no study that investigated the olfactory accumulation of Mn in humans despite the evidence from studies in laboratory animals that suggests an olfactory route of Mn to the brain. The present study was designed to investigate the Mn accumulation in different brain regions and to explore their functional correlations.

MATERIALS AND METHODS

Subjects.

Seven welders (48 ± 13 years) and seven controls (50 ± 12 years) were recruited from the community for this study (see detailed demographic information in Table 1). All subjects were male and answered negatively for past diagnosis of PD and Parkinson's symptoms (see Supplementary appendix A, Questions 17 and 18). As a part of the screening visit, a detailed clinical history was taken for all subjects that included age, education, history of smoking, and history of current and/or past major medical/neurological disorders. All subjects were also examined and ascertained to be free of any obvious neurological and movement deficits (scored zero on Unified Parkinson's Disease Rating Scales, motor subscales) and any obvious cognitive deficits (Mini-Mental Status Examination [MMSE] above 28). All subjects had normal liver function test and blood calcium and magnesium levels. All welders also underwent an orbital radiograph to rule out any metal fragments around the orbit. Written informed consent was obtained from all subjects in accordance to the Internal Review Board/Human Subjects Protection Office guidelines of Penn State University, Hershey Medical Center.

TABLE 1.

Demographic Data

Welders (n = 7) Controls (n = 7) p Value
Age (years) 48 (± 13) 50 (± 12) 0.79
Education (years) 12 13.9 (± 1.9) 0.039*
Current regular smoker 1/7 0 1
Durations of welding (years) 24.1 (± 15.5) 0 0.006*
Cumulative Mn exposure (mg/m3—years) 0.881 (± 0.567) 0.002 (± 0.0003) 0.006*
MMSE 29.6 (± 0.8) 29.7 (± 0.5) 0.69
Blood chemistry Aspartate aminotransferase (units/l) 34 (± 4.6) 36 (± 6) 0.49
Alanine aminotransferase (units/l) 26.9 (± 9.5) 26.6 (± 7.9) 0.95
Calcium (mmol/l) 9.8 (± 0.7) 9.4 (± 0.3) 0.20
Magnesium (mmol/l) 2.0 (± 0.2) 2.0 (± 0.1) 0.72

Note. Means and SDs of demographic data for welders and controls. p Value is derived after performing a Student's t-test between the two groups; except education, duration of welding, and cumulative Mn exposure where t-test was performed assuming unequal variances.

*Indicates significant differences (p < 0.05) between welders and controls.

Occupational Mn Exposure Assessment.

Mn exposure was estimated by a detailed occupational questionnaire (Supplementary appendix A). Occupation-related questions included if the person was still employed as a welder and for how many years he had been welding. Other occupational questions included an estimate of what percentage of time on the job was related to welding (ranging from less than 25% to greater than 75%), where did the welding occur (indoors or outdoors), whether respiratory protection was worn, the ventilation at the workplace, the kind of welding primarily done (shielded metal arc, metal inert gas, heliarc, flux cored, other gas welding, or brazing), the kind of welding stick primarily used, the type of metal being welded, and how often welding occurred in confined spaces. Behavioral questions included whether individuals were primarily nose or mouth breathers, their smoking habits, and if they had worked in close contact with pesticides.

The cumulative lifetime exposures (Ec) to airborne Mn were determined for all subjects using the following formula:

graphic file with name toxscikfr033fx1_ht.jpg

Where TW = the time (in years), on the job working as a welder (assumes 40 h work week); Ec = the cumulative lifetime exposure to Mn in milligrams per cubic meter—years; YT = the welder's age in years; YW = the number of years employed as a welder; C-W = the average concentration of Mn exposure during welding in milligrams per cubic meter; and C-A = the average concentration of Mn in ambient air in milligrams per cubic meter.

graphic file with name toxscikfr033fx2_ht.jpg

This analysis assumes that the exposures measured for the welder during his welding time included the exposure from ambient air as well. For all controls, CW was zero. An average ambient air exposure for Mn (C-A) of 0.00003 mg/m3 is assigned to all subjects based on the Agency for Toxic Substances and Disease Registry (U.S. DHHS, 2008) (for further details of determining exposure levels from different types of welding, see Supplementary appendix B).

Functional Testing.

Functional testing was performed on the same day as the screening visit. The Grooved Pegboard test was administered for both hands for all subjects as instructed by the accompanying manual (Lafayette Instrument Inc., Purdue, IN). Briefly, the subject is asked to pick the pegs one at a time using one hand and fill the board. For the right hand, the board is filled from left to right for each row beginning from the top. For the left hand, the board is filled from right to left for each row. The trial is done first with the dominant hand and then the nondominant hand. The total score is a sum of the time taken in seconds, total number of pegs dropped, and the total number of pegs correctly placed in the board.

The Trail making (parts A [TMT-A] and B [TMT-B]) (Reitan and Wolfson, 1995) also were administered to all subjects. Briefly, the TMT-A consists of numbers (1–25) within circles on a sheet of paper. The subject is asked to connect them sequentially and as quickly as possible without lifting the pen from the sheet. TMT-B consists of numbers (1–13) and letters (A–L) within circles. The subject is asked to connect the circles as before, but this time alternating between numbers and letters (e.g. 1-A-2-B-3-C, etc.). If the subject makes a mistake, he is asked to return to the last correct response and start again. The score is the total time taken to correctly complete the test.

The 40-item University of Pennsylvania Smell Identification Test (UPSIT) (Doty et al., 1984) was mailed to all subjects for self-administration. Thirteen subjects (seven welders and six controls) returned the tests.

Magnetic Resonance Imaging.

All subjects had their MRI scans done within 1 week of the screening visit. All images were acquired using a Siemens 3-T TrioTim MRI, with an 8-channel birdcage type In Vivo coil. First, a set of high-resolution T1W images (3D Multi Planar Reformatting, Repetition Time (TR) = 1540 ms, Echo Time (TE) = 2.3 ms, voxel spacing 1 × 1 × 1, image resolution 256 × 256, 176 slices) was acquired for anatomical segmentation and mean intensity analysis. For estimating T1 relaxation time of the OB, coronal images were acquired by positioning the image acquisition grid perpendicular to the base of the frontal lobe, from anterior of the orbits to the anterior of the central sulcus, using multiple flip angles 10°, 20°, 30°, 45°, and 60° (3D gradient echo [GRE], TR = 35 ms, TE = 2 ms, voxel spacing 0.5 × 0.5 × 1.5, image resolution 128 × 128, 50 slices).

MRI Data Analysis.
Defining regions of interest.

Bilateral globus pallidus (GP) and frontal gray matter (FGM) (Fig. 1A) were defined using automatic segmentation software (AutoSeg) (Gouttard et al., 2007; Joshi et al., 2004) for each subject, whereas the frontal white matter (FWM) (Fig. 1B) was defined by a semi-automatic segmentation method in InsightSNAP (ITK-SNAP) (Yushkevich et al., 2006) on the T1W images. The OB, including both the OB neurons and surrounding epithelium (Fig. 1C), was defined by manually drawing a region of interest (ROI) on the coronal T1 image for all subjects by the same rater. Mean signal intensity and T1 values of all the voxels in the individual ROIs were calculated.

FIG. 1.

FIG. 1.

Segmentation of the MRI brain images were performed using (A) automatic segmentation software (AutoSeg) to obtain the FGM (red) and GP (green) and (B) a semi-automatic segmentation method (ITK-SNAP) to yield the FWM. The OB and the surrounding epithelium (C) were hand drawn by the same rater for all subjects.

Estimation of T1 relaxation time in OB.

To estimate the T1 relaxation time, the data from the 3D GRE MRI images acquired with multiple flip angles were fit into the following equation:Inline graphic (Haacke et al., 1999), where s(θ) is the MR signal acquired at the specific flip angle θ, M0 is the spin density, and E1=eTR/T1. After linear curve fitting, the computed slope reflects E1, which in turn gives the estimate of T1. Computation was done using an in-house program written on MATLAB (Mathwork Inc.). The T1 relaxation rates (R1 = 1/T1) of the OB were computed from the mean T1 relaxation time.

Estimation of intensity in T1W images.

To take into account variations in intensity of T1W images caused by imperfect magnetic fields, both within subjects and between subjects, a postacquisition image processing method was employed to correct the signal intensity variation. First, a bias field correction was used to reduce inhomogeneity within subjects for each scan using the standard, fully automatic FMRIB software library brain extraction tool with bias field and neck cleanup (Smith, 2002). Subsequently, histogram-based intensity standardization was used to correct inhomogeneities between subjects according to a recently published method (Ge et al., 2000; Nyul et al., 2000) that was implemented by a person blinded to welding exposure status. The mean intensities of all voxels in each ROI (i.e., GP, FWM, and FGM) for individual subjects were extracted using ITK-SNAP. Because the image processing procedure involves skull stripping (including the removal of nasal conchae, OB, and orbits) for internal bias removal, mean intensity of the OB could not be calculated. The pallidal index (PI) was derived from the ratio of GP intensity to FWM intensity (PI = GP/FWM) (Krieger et al., 1995).

Statistical Analysis.

Comparison of the demographic information, specifically age, MMSE, blood chemistry results, and MRI data, between welder and control groups was conducted using Student's t-test. Cumulative Mn exposures, duration of welding, and education between the welder and control groups were compared by t-tests assuming unequal variances. Smell test results were explored by comparing both raw scores, as well as the age-adjusted percentile scores, in a one-way ANOVA between the two groups. Analysis of covariance was used to test the group differences for the Grooved Pegboard test and the Trail-making test; age was the independent variable and welder or control was the group variable. Grooved Pegboard test scores for the dominant and nondominant hands were regressed on the mean signal intensity of FGM, GP, putamen, and FWM for all subjects. Correlations between variables were tested at a 95% confidence interval and p values less than 0.05 were considered significant. All statistical analyses were performed on JMP 8.0.1 statistical software (SAS Institute Inc. Cary, NC).

RESULTS

There were no significant differences in age, MMSE, and blood chemistry between welders and controls. Welders had a lower education level and significantly higher cumulative Mn exposures compared with controls (Table 1). As seen in Table 2, welders scored significantly worse than controls on the Grooved Pegboard test for the nondominant hand (p = 0.03) and displayed a similar trend for the dominant hand (p = 0.06). There were, however, no significant differences in the Trail-making test (TMT-A [p = 0.58] and TMT-B [p = 0.29]) between welders and controls (Table 2). There was also no significant difference in either the UPSIT score (p = 0.66) or the age-adjusted UPSIT percentile scores (p = 0.74) between welders and controls (Table 2).

TABLE 2.

Mean and SD for Welders and Age- and Gender-Matched Controls on Neurobehavioral Tasks and Olfactory Tests

Welders (n = 7) Controls (n = 7) p Value
Grooved Pegboard scores (s) Dominant 76.1 (± 10) 66.9 (± 11) 0.06
Nondominant 87 (± 11) 73.7 (± 11) 0.03*
Trails test scores (s) TMT-A 21.3 (± 7) 19.4 (± 4) 0.58
TMT-B 56.7 (± 22) 44.9 (± 17) 0.29
UPSIT test UPSIT score 34.7 (± 4.3) 35.7 (± 3.1) 0.66
UPSIT percentile score 51.6 (± 30.5) 57 (± 27) 0.74

Note. Means and SDs of neurobehavioral and olfactory test scores of welders and controls. Olfactory test was self-administered by seven welders and six controls. p Value for Grooved Pegboard scores and Trails test scores were derived from analysis of covariance between the two groups after controlling for age. p Values for UPSIT scores were derived from one-way ANOVA between the two groups.

The volumes of all brain ROIs were not significantly different between welders and controls (data not shown). We also did not detect any hyperintense signal in the GP, putamen, and FGM in any of the welders by naked eye (see Supplementary appendix C, figure). Compared with controls, welders had significantly higher R1 values of OB (p = 0.02; Fig. 2A). In addition, the welders also had significantly higher T1W mean intensity of FWM (p = 0.01), GP (p = 0.03), and putamen (p = 0.03) (Fig. 2B) compared with controls. There was, however, no significant difference in the T1W mean intensity of the FGM (p = 0.22) and PI (p = 0.32; Fig. 2C) between controls and welders.

FIG. 2.

FIG. 2.

Student's T-tests were conducted to compare between welders (black columns) and controls (gray columns). (A) The OB, T1 relaxation rate (R1); (B) the T1W intensity (T1WI) of the FGM, GP, and FWM; and (C) the PI. p Values less than 0.05 at a 95% confidence interval were considered significant.

The Grooved Pegboard performance of the dominant hand (Fig. 3 upper panel) displayed a positive correlation with the mean intensity of FGM (R2 = 0.42, p = 0.012), GP (R2 = 0.51, p = 0.004), putamen (R2 = 0.49, p = 0.006), and FWM (R2 = 0.51, p = 0.004) in all subjects. The Grooved Pegboard performance of the nondominant hand had significant correlation (Fig. 3 lower panel) with FWM (R2 = 0.37, p = 0.02) only and fell just short of significance with GP (R2 = 0.28, p = 0.05). There were also no correlations between the Grooved Pegboard scores and PI for either the dominant hand (R2 = 0.006, p = 0.8) or the nondominant hand (R2 = 0.1, p = 0.26). There was also no significant correlation between the R1 values of OB and smell test performances (R2 = 0.06, p = 0.41) in all subjects (data not shown).

FIG. 3.

FIG. 3.

Multiple regression analyses between T1W-MRI results and Grooved Pegboard scores from the nondominant and dominant hands of welders (solid circles) and controls (open circles). Correlation of FGM with scores of (A) dominant hand (R2 = 0.42, p = 0.01) and (E) nondominant hand (R2 = 0.21, p = 0.1); GP with scores from (B) dominant hand (R2 = 0.51, p = 0.004) and (F) nondominant hand (R2 = 0.28, p = 0.05); putamen with scores of (C) dominant hand (R2 = 0.49, p = 0.006) and (G) nondominant hand (R2 = 0.24, p = 0.07); FWM with scores of (D) dominant hand (R2 = 0.51, p = 0.004) and (H) nondominant hand (R2 = 0.37, p = 0.02). All analyses were performed with a 95% confidence interval.

DISCUSSION

To our knowledge, this is the first study to demonstrate higher T1 relaxation rates due to Mn accumulation in the OB of “asymptomatic” welders. This is consistent with the hypothesis that the olfactory nerve might be one of the routes of entry of Mn into the brain. This study also suggests that there is Mn accumulation in many other regions of the brain in asymptomatic welders and supports the importance of broadening the investigation of Mn exposure to regions of the brain other than just the pallidus. Lastly, our study provides preliminary evidence that there were potential brain region–specific neurobehavioral consequences of the subclinical Mn exposure that warrant further investigation.

The exact mechanisms by which Mn reaches different brain regions are not completely understood. Mn transport into the brain may occur via three pathways (Crossgrove and Zheng, 2004): (1) transport across the BBB by transporter-mediated kinetics, (2) transport across the blood-cerebrospinal fluid barrier of the choroid plexus, and (3) via the olfactory nerve bypassing the BBB. Of particular relevance are studies in laboratory animals showing that soluble metal particles (Chuang and Koretsky, 2006; Henriksson et al., 1999; Tjalve et al., 1996) as well as insoluble metal and nonmetal particles (Elder et al., 2006; Oberdorster et al., 2004; Wang et al., 2007, 2008) can be transported along the olfactory nerve directly into the OB and further into the central nervous system, bypassing the protective BBB. Furthermore, MRI studies of nonhuman primates exposed to aerosolized MnSO4 demonstrated Mn accumulation in the OB (Dorman et al., 2006a,b). Although past reports have alluded to Mn distribution to the OB (Chu et al., 1995; Fitsanakis et al., 2006), we believe that this is the first MRI study in humans supporting the OB as a potential point of entry for Mn particles from welding fumes, as shown by high T1 relaxation rates in the OB.

It is conceivable that Mn may reach different brain regions through different mechanisms, thereby accumulating in varying rates and concentrations. After Mn is distributed to the brain tissue, intracranial Mn is known to have a very slow clearance rate (Newland et al., 1989), where it is primarily sequestered in tissue and intracellular compartments. The tissue half-life of Mn in brain has been reported to exceed 50 days (Newland et al., 1987; Takeda et al., 1995). MRI has been used to estimate Mn accumulation in the brain (Chang et al., 2009, 2010; Dorman et al., 2006b; Krieger et al., 1995) by calculating the PI, but a major deficiency of this approach is that it neglects brain tissues other than the GP (Dorman et al., 2006b; Maeda et al., 1997) and might be less sensitive to lower, subclinical levels of Mn exposure (Dorman et al. 2006a,b). Because none of our welders had any overt symptoms of Mn toxicity, it is not surprising that we neither detected any obvious hyperintense signals in the basal ganglia by naked eye (see Supplementary appendix C, figure) nor a significant higher PI in these asymptomatic welders. An obvious reason for the PI being less sensitive is that it is a ratio of GP intensity to FWM intensity, and because both these measures are significantly different between welders with subclinical Mn exposure and controls, the ratio of the two tissues may cancel out some of the Mn effects. The results of our study are consistent with this notion that Mn accumulates in regions outside of the pallidus in a region-specific manner; furthermore, some of these regions (e.g., OB and FWM) are more sensitive for detecting the differences between welders and controls than the PI.

Consistent with past studies (Bowler et al., 2006a; Chang et al., 2009; Ellingsen et al., 2008), we also found that welders performed worse than controls on the Grooved Pegboard test, but not on the Trail-making test. Few studies, however, had correlated the Grooved Pegboard tests with MRI findings. Chang et al. (2009, 2010) recently reported that the scores of the Grooved Pegboard test with the dominant hand correlated with blood Mn level and PI, the two most common exposure measurements. Although the number of subjects in that study was larger (43 welders) than in the current study, the correlations between functional and exposure correlations were weak (R2 < 0.20). In our study, the correlations of Grooved Pegboard test scores were much stronger (R2 > 0.40) with region-specific Mn accumulation. This supports that region-specific Mn accumulation may be a more clinically relevant marker for Mn exposure.

It is also worth noting that we observed a correlation of T1 intensity and Grooved Pegboard scores among controls as well. Many factors may contribute to the variations in either T1 intensity or motor skill testing in normal subjects. As we noted above, all subjects, even controls, are exposed to some concentration of Mn from ambient air. It is possible that some of the functional variations in controls are due to differences in Mn accumulation in the brain. This may result from several different exposure sources, including drinking water (Bouchard et al., 2011; Environmental Protection Agency, 2004), urban living (Willis et al., 2010), nearby ferromanganese alloy plants (Lucchini et al., 2007; Menezes-Filho et al., 2011), and the like. Previous reports have shown that aging also can affect both pegboard performance (Ruff and Parker, 1993) and MRI T1 intensity (Cho et al., 1997). In this context, it will be worthwhile investigating whether environmental Mn exposure affects T1W imaging and contributes to aging-related cognitive decline in the general population.

Decreased olfactory function in welders has been previously reported (Antunes et al., 2007; Lucchini et al., 1997; Mergler et al., 1994). Our study of the seven welders and six controls failed to find a difference in the olfactory function between the two groups or any clear correlations between the smell test and R1 in OB. This may be due to our small sample size, relative to the study of Antunes et al. (2007) of 42 welders and 42 controls. Nevertheless, future studies with larger sample size are warranted to investigate the olfactory dysfunction and its relationship with Mn accumulation in OB.

There are other limitations to our study besides a small sample size. For example, welding fumes contain several other metals including Fe and copper that are known to be neurotoxic and chromium and nickel that are known to be more carcinogenic. Fe exposures tend to be well correlated with Mn exposures for many types of welding and have been determined to be about 10 times the Mn levels based on the analysis of several data sets (Flynn and Susi, 2011). Compared with Mn, both chromium and nickel are present in trace amounts in most welding wires but are not consistently detected in welding fumes unless stainless steels are involved (Jenkins and Eagar, 2005; Sowards et al., 2010). Even though Fe is the predominant component of welding wires and welding fumes, Fe itself has a very small T1 relaxivity (0.01 mM−1s−1) compared with Mn (7.1 mM−1s−1) (Yilmaz et al., 1999). Additionally, using a nonlinear competition model that accounts for Mn and Fe, Zhang et al. (2009) found that bound Mn, rather than Fe, is the most likely cause for the increase in T1 relaxation rates in different brain regions, particularly the striatum. Furthermore, a recent study that exposed rats to welding fumes via intratracheal instillation also showed that only Mn in welding fumes is distributed to the brain, whereas other metals (Cr, Fe, and Cu) are not (Antonini et al., 2010). Thus, based on existing data and literature, we can conclude that the changes in T1W intensity and relaxation rates we observe in welders are primarily due to Mn. Nevertheless, further studies with larger sample size are required to properly assess the contribution of these other metals to neurobehavioral changes observed in welders.

SUPPLEMENTARY DATA

Supplementary data are available online at http://toxsci.oxfordjournals.org/.

Supplementary Data

FUNDING

National Institute of Environmental Health Sciences (T32ES07018; University of North Carolina, Department of Biostatistics); National Institute of Neurological Disorders and Stroke (NS060722; Pennsylvania State University, Department of Neurology); General Clinical Research Center Grant from National Institutes of Health (M01RR10732), and General Clinical Research Center Construction Grant (C06RR016499), Pennsylvania State University, College of Medicine.

Acknowledgments

The authors would like to thank all those who participated in this study. The authors are indebted to Dr David Dorman for the suggestion of pursuing OB MRI studies in humans, to Jeff Vesek and the personnel at Penn State Hershey Center for NMR Research for use of their MRI facilities, and to Dr Richard Mailman and Dr Qing X. Yang for their comments and suggestions.

References

  1. Antonini JM, Roberts JR, Chapman RS, Soukup JM, Ghio AJ, Sriram K. Pulmonary toxicity and extrapulmonary tissue distribution of metals after repeated exposure to different welding fumes. Inhal. Toxicol. 2010;22:805–816. doi: 10.3109/08958371003621641. [DOI] [PubMed] [Google Scholar]
  2. Antonini JM, Sriram K, Benkovic SA, Roberts JR, Stone S, Chen BT, Schwegler-Berry D, Jefferson AM, Billig BK, Felton CM, et al. Mild steel welding fume causes manganese accumulation and subtle neuroinflammatory changes but not overt neuronal damage in discrete brain regions of rats after short-term inhalation exposure. Neurotoxicology. 2009;30:915–925. doi: 10.1016/j.neuro.2009.09.006. [DOI] [PubMed] [Google Scholar]
  3. Antunes MB, Bowler R, Doty RL. San Francisco/Oakland Bay Bridge Welder Study: olfactory function. Neurology. 2007;69:1278–1284. doi: 10.1212/01.wnl.0000276988.50742.5e. [DOI] [PubMed] [Google Scholar]
  4. Bock NA, Paiva FF, Nascimento GC, Newman JD, Silva AC. Cerebrospinal fluid to brain transport of manganese in a non-human primate revealed by MRI. Brain Res. 2008;1198:160–170. doi: 10.1016/j.brainres.2007.12.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bouchard MF, Sauve S, Barbeau B, Legrand M, Brodeur ME, Bouffard T, Limoges E, Bellinger DC, Mergler D. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ. Health Perspect. 2011;119:138–143. doi: 10.1289/ehp.1002321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bowler RM, Gysens S, Diamond E, Nakagawa S, Drezgic M, Roels HA. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. Neurotoxicology. 2006a;27:315–326. doi: 10.1016/j.neuro.2005.10.007. [DOI] [PubMed] [Google Scholar]
  7. Bowler RM, Koller W, Schulz PE. Parkinsonism due to manganism in a welder: neurological and neuropsychological sequelae. Neurotoxicology. 2006b;27:327–332. doi: 10.1016/j.neuro.2005.10.011. [DOI] [PubMed] [Google Scholar]
  8. Chang Y, Kim Y, Woo ST, Song HJ, Kim SH, Lee H, Kwon YJ, Ahn JH, Park SJ, Chung IS, et al. High signal intensity on magnetic resonance imaging is a better predictor of neurobehavioral performances than blood manganese in asymptomatic welders. Neurotoxicology. 2009;30:555–563. doi: 10.1016/j.neuro.2009.04.002. [DOI] [PubMed] [Google Scholar]
  9. Chang Y, Woo ST, Kim Y, Lee JJ, Song HJ, Lee HJ, Kim SH, Lee H, Kwon YJ, Ahn JH, et al. Pallidal index measured with three-dimensional T1-weighted gradient echo sequence is a good predictor of manganese exposure in welders. J. Magn Reson. Imaging. 2010;31:1020–1026. doi: 10.1002/jmri.22104. [DOI] [PubMed] [Google Scholar]
  10. Cho S, Jones D, Reddick WE, Ogg RJ, Steen RG. Establishing norms for age-related changes in proton T1 of human brain tissue in vivo. Magn. Reson. Imaging. 1997;15:1133–1143. doi: 10.1016/s0730-725x(97)00202-6. [DOI] [PubMed] [Google Scholar]
  11. Choi DS, Kim EA, Cheong HK, Khang HS, Ryoo JW, Cho JM, Sakong J, Park I. Evaluation of MR signal index for the assessment of occupational manganese exposure of welders by measurement of local proton T1 relaxation time. Neurotoxicology. 2007;28:284–289. doi: 10.1016/j.neuro.2006.05.020. [DOI] [PubMed] [Google Scholar]
  12. Chu NS, Hochberg FH, Calne DB, Olanow CW. Handbook of Neurotoxicity (L. W. Chang and R. S. Dyner, Eds.) New York: Marcel Dekker; 1995. Neurotoxicology of manganese; pp. 91–103. [Google Scholar]
  13. Chuang KH, Koretsky A. Improved neuronal tract tracing using manganese enhanced magnetic resonance imaging with fast T(1) mapping. Magn. Reson. Med. 2006;55:604–611. doi: 10.1002/mrm.20797. [DOI] [PubMed] [Google Scholar]
  14. Couper J. Sur les effets du peroxide de manganèse. J. Chim. Méd. Pharm. Toxicol. 1837;3:223–225. [Google Scholar]
  15. Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004;17:544–553. doi: 10.1002/nbm.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. da Silva CJ, da Rocha AJ, Mendes MF, Braga AP, Jeronymo S. Brain manganese deposition depicted by magnetic resonance imaging in a welder. Arch. Neurol. 2008;65:983. doi: 10.1001/archneur.65.7.983. [DOI] [PubMed] [Google Scholar]
  17. Dorman DC, Struve MF, James RA, Marshall MW, Parkinson CU, Wong BA. Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure. Toxicol. Appl. Pharmacol. 2001;170:79–87. doi: 10.1006/taap.2000.9088. [DOI] [PubMed] [Google Scholar]
  18. Dorman DC, Struve MF, Marshall MW, Parkinson CU, James RA, Wong BA. Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation. Toxicol. Sci. 2006a;92:201–210. doi: 10.1093/toxsci/kfj206. [DOI] [PubMed] [Google Scholar]
  19. Dorman DC, Struve MF, Wong BA, Dye JA, Robertson ID. Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation. Toxicol. Sci. 2006b;92:219–227. doi: 10.1093/toxsci/kfj209. [DOI] [PubMed] [Google Scholar]
  20. Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94(Pt 1):176–178. doi: 10.1288/00005537-198402000-00004. [DOI] [PubMed] [Google Scholar]
  21. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 2006;114:1172–1178. doi: 10.1289/ehp.9030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ellingsen DG, Konstantinov R, Bast-Pettersen R, Merkurjeva L, Chashchin M, Thomassen Y, Chashchin V. A neurobehavioral study of current and former welders exposed to manganese. Neurotoxicology. 2008;29:48–59. doi: 10.1016/j.neuro.2007.08.014. [DOI] [PubMed] [Google Scholar]
  23. Environmental Protection Agency (EPA) Drinking Water Advisory for Manganese. 2004. Available at: http://www.epa.gov/ogwdw/ccl/pdfs/reg_determine1/support_cc1_magnese_dwreport.pdf. Accessed March 9, 2011. [Google Scholar]
  24. Environmental Protection Agency (EPA) Manganese (CASRN 7439-96-5). Environmental Protection Agency; 2010. Available at: http://www.epa.gov/iris/subst/0373.htm. Accessed January 1, 2010. [Google Scholar]
  25. Fitsanakis VA, Zhang N, Anderson JG, Erikson KM, Avison MJ, Gore JC, Aschner M. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol. Sci. 2008;103:116–124. doi: 10.1093/toxsci/kfn019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Fitsanakis VA, Zhang N, Avison MJ, Gore JC, Aschner JL, Aschner M. The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology. 2006;27:798–806. doi: 10.1016/j.neuro.2006.03.001. [DOI] [PubMed] [Google Scholar]
  27. Flynn MR, Susi P. Manganese, iron, and total particulate exposures to welders. J. Occup. Environ. Hyg. 2010;7:115–126. doi: 10.1080/15459620903454600. [DOI] [PubMed] [Google Scholar]
  28. Ge Y, Udupa JK, Nyul LG, Wei L, Grossman RI. Numerical tissue characterization in MS via standardization of the MR image intensity scale. J. Magn. Reson. Imaging. 2000;12:715–721. doi: 10.1002/1522-2586(200011)12:5<715::aid-jmri8>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  29. Gouttard S, Styner M, Joshi S, Smith RG, Hazlett HC, Gerig G. Subcortical structure segmentation using probabilistic atlas priors, pp. 2007:37–46. Medical Image Computing and Computer Assisted Intervention. Workshop on 3D Segmentation in the Clinic–A Grand Challenge, October 2007, Brisbane, Australia. [Google Scholar]
  30. Guilarte TR. Manganese and Parkinson's disease: a critical review and new findings. Environ. Health Perspect. 2010;118:1071–1080. doi: 10.1289/ehp.0901748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic Resonance I maging Physical Principles and Sequence Design. New York, NY: Wiley; 1999. [Google Scholar]
  32. Heilig EA, Thompson KJ, Molina RM, Ivanov AR, Brain JD, Wessling-Resnick M. Manganese and iron transport across pulmonary epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;290:L1247–L1259. doi: 10.1152/ajplung.00450.2005. [DOI] [PubMed] [Google Scholar]
  33. Henriksson J, Tallkvist J, Tjalve H. Transport of manganese via the olfactory pathway in rats: dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain. Toxicol. Appl. Pharmacol. 1999;156:119–128. doi: 10.1006/taap.1999.8639. [DOI] [PubMed] [Google Scholar]
  34. Huang CC, Lu CS, Chu NS, Hochberg F, Lilienfeld D, Olanow W, Calne DB. Progression after chronic manganese exposure. Neurology. 1993;43:1479–1483. doi: 10.1212/wnl.43.8.1479. [DOI] [PubMed] [Google Scholar]
  35. Jenkins NT, Eagar TW. Chemical analysis of welding fume particles—airborne particle size is the most important factor in determining the accuracy of a method for chemical analysis. Weld. J. 2005;84:87S–93S. [Google Scholar]
  36. Joshi S, Davis B, Jomier M, Gerig G. Unbiased diffeomorphic atlas construction for computational anatomy. Neuroimage. 2004;23(Suppl. 1):S151–S160. doi: 10.1016/j.neuroimage.2004.07.068. [DOI] [PubMed] [Google Scholar]
  37. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet. 1995;346:270–274. doi: 10.1016/s0140-6736(95)92164-8. [DOI] [PubMed] [Google Scholar]
  38. Lam HF, Hewitt PJ, Hicks R. A study of pulmonary deposition, and the elimination of some constituent metals from welding fume in laboratory animals. Ann. Occup. Hyg. 1978;21:363–373. doi: 10.1093/annhyg/21.4.363. [DOI] [PubMed] [Google Scholar]
  39. Lucchini R, Bergamaschi E, Smargiassi A, Festa D, Apostoli P. Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ. Res. 1997;73:175–180. doi: 10.1006/enrs.1997.3702. [DOI] [PubMed] [Google Scholar]
  40. Lucchini RG, Albini E, Benedetti L, Borghesi S, Coccaglio R, Malara EC, Parrinello G, Garattini S, Resola S, Alessio L. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am. J. Ind. Med. 2007;50:788–800. doi: 10.1002/ajim.20494. [DOI] [PubMed] [Google Scholar]
  41. Maeda H, Sato M, Yoshikawa A, Kimura M, Sonomura T, Terada M, Kishi K. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology. 1997;39:546–550. doi: 10.1007/s002340050464. [DOI] [PubMed] [Google Scholar]
  42. Menezes-Filho JA, Novaes CD, Moreira JC, Sarcinelli PN, Mergler D. Elevated manganese and cognitive performance in school-aged children and their mothers. Environ. Res. 2011;111:156–163. doi: 10.1016/j.envres.2010.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Mergler D, Baldwin M. Early manifestations of manganese neurotoxicity in humans: an update. Environ. Res. 1997;73:92–100. doi: 10.1006/enrs.1997.3710. [DOI] [PubMed] [Google Scholar]
  44. Mergler D, Huel G, Bowler R, Iregren A, Belanger S, Baldwin M, Tardif R, Smargiassi A, Martin L. Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 1994;64:151–180. doi: 10.1006/enrs.1994.1013. [DOI] [PubMed] [Google Scholar]
  45. Meyer-Baron M, Knapp G, Schaper M, van TC. Performance alterations associated with occupational exposure to manganese—a meta-analysis. Neurotoxicology. 2009;30:487–496. doi: 10.1016/j.neuro.2009.05.001. [DOI] [PubMed] [Google Scholar]
  46. Newland MC, Ceckler TL, Kordower JH, Weiss B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp. Neurol. 1989;106:251–258. doi: 10.1016/0014-4886(89)90157-x. [DOI] [PubMed] [Google Scholar]
  47. Newland MC, Cox C, Hamada R, Oberdorster G, Weiss B. The clearance of manganese chloride in the primate. Fundam. Appl. Toxicol. 1987;9:314–328. doi: 10.1016/0272-0590(87)90054-6. [DOI] [PubMed] [Google Scholar]
  48. Nyul LG, Udupa JK, Zhang X. New variants of a method of MRI scale standardization. IEEE Trans. Med. Imaging. 2000;19:143–150. doi: 10.1109/42.836373. [DOI] [PubMed] [Google Scholar]
  49. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004;16:437–445. doi: 10.1080/08958370490439597. [DOI] [PubMed] [Google Scholar]
  50. Occupational Safety and Health Administration (OSHA) Occupational Safety and Health Guideline for Welding Fumes. 2009. Available at: http://www.osha.gov/SLTC/healthguidelines/weldingfumes/recognition.html. Accessed June 12, 2009. [Google Scholar]
  51. Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, Snow BJ, Beal MF, Calne DB, Perl DP. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology. 1996;46:492–498. doi: 10.1212/wnl.46.2.492. [DOI] [PubMed] [Google Scholar]
  52. Ostiguy C, Asselin P, Malo S. The emergence of manganese-related health problems in Quebec: an integrated approach to evaluation, diagnosis, management and control. Neurotoxicology. 2006;27:350–356. doi: 10.1016/j.neuro.2005.11.001. [DOI] [PubMed] [Google Scholar]
  53. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology. 1999;20:227–238. [PubMed] [Google Scholar]
  54. Quaghebeur G, Taylor WJ, Kingsley DP, Fell JM, Reynolds AP, Milla PJ. MRI in children receiving total parenteral nutrition. Neuroradiology. 1996;38:680–683. doi: 10.1007/s002340050333. [DOI] [PubMed] [Google Scholar]
  55. Reaney SH, Bench G, Smith DR. Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol. Sci. 2006;93:114–124. doi: 10.1093/toxsci/kfl028. [DOI] [PubMed] [Google Scholar]
  56. Reitan RM, Wolfson D. Category test and Trail making test as measures of frontal-lobe functions. Clin. Neuropsychol. 1995;9:50–56. [Google Scholar]
  57. Ruff RM, Parker SB. Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests. Percept. Mot. Skills. 1993;76(Pt 2):1219–1230. doi: 10.2466/pms.1993.76.3c.1219. [DOI] [PubMed] [Google Scholar]
  58. Selikhova M, Fedoryshyn L, Matviyenko Y, Komnatska I, Kyrylchuk M, Krolicki L, Friedman A, Taylor A, Jager HR, Lees A, et al. Parkinsonism and dystonia caused by the illicit use of ephedrone—a longitudinal study. Mov. Disord. 2008;23:2224–2231. doi: 10.1002/mds.22290. [DOI] [PubMed] [Google Scholar]
  59. Silva AC, Bock NA. Manganese-enhanced MRI: an exceptional tool in translational neuroimaging. Schizophr. Bull. 2008;34:595–604. doi: 10.1093/schbul/sbn056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Smith SM. Fast robust automated brain extraction. Hum. Brain Mapp. 2002;17:143–155. doi: 10.1002/hbm.10062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sowards JW, Ramirez AJ, Dickinson DW, Lippold JC. Characterization of welding fume from SMAW electrodes—Part II. Weld. J. 2010;89:82S–90S. [Google Scholar]
  62. Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkajis A, Martinsone I, Terauds E, Rozentale B, Donaghy M. A Parkinsonian syndrome in methcathinone users and the role of manganese. N. Engl. J. Med. 2008;358:1009–1017. doi: 10.1056/NEJMoa072488. [DOI] [PubMed] [Google Scholar]
  63. Takeda A, Sawashita J, Okada S. Biological half-lives of zinc and manganese in rat brain. Brain Res. 1995;695:53–58. doi: 10.1016/0006-8993(95)00916-e. [DOI] [PubMed] [Google Scholar]
  64. Tjalve H, Henriksson J, Tallkvist J, Larsson BS, Lindquist NG. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol. Toxicol. 1996;79:347–356. doi: 10.1111/j.1600-0773.1996.tb00021.x. [DOI] [PubMed] [Google Scholar]
  65. U.S. Department of Health and Human Services (U.S.DHHS) Draft Toxicological Profile For Manganese. 2008. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp151.pdf. Accessed March 8, 2011. [Google Scholar]
  66. Wang B, Feng WY, Wang M, Shi JW, Zhang F, Ouyang H, Zhao YL, Chai ZF, Huang YY, Xie YN, et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol. Trace Elem. Res. 2007;118:233–243. doi: 10.1007/s12011-007-0028-6. [DOI] [PubMed] [Google Scholar]
  67. Wang J, Liu Y, Jiao F, Lao F, Li W, Gu Y, Li Y, Ge C, Zhou G, Li B, et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology. 2008;254:82–90. doi: 10.1016/j.tox.2008.09.014. [DOI] [PubMed] [Google Scholar]
  68. Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, Racette BA. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am. J. Epidemiol. 2010;172:1357–1363. doi: 10.1093/aje/kwq303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Yilmaz A, Yurdakoc M, Isik B. Influence of transition metal ions on NMR proton T1 relaxation times of serum, blood, and red cells. Biol. Trace Elem. Res. 1999;67:187–193. doi: 10.1007/BF02784073. [DOI] [PubMed] [Google Scholar]
  70. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31:1116–1128. doi: 10.1016/j.neuroimage.2006.01.015. [DOI] [PubMed] [Google Scholar]
  71. Zhang N, Fitsanakis VA, Erikson KM, Aschner M, Avison MJ, Gore JC. A model for the analysis of competitive relaxation effects of manganese and iron in vivo. NMR Biomed. 2009;22:391–404. doi: 10.1002/nbm.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

Articles from Toxicological Sciences are provided here courtesy of Oxford University Press

RESOURCES